New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces Addition to Russell 2000 Index
June 29, 2015 08:00 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., June 29, 2015 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics to Present at the JMP Securities Life Science Conference June 24th
June 17, 2015 08:00 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., June 17, 2015 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Appoints Scott Toner as Senior Vice President of Marketing
June 02, 2015 08:00 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., June 2, 2015 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq: PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics to Present at Upcoming ERA-EDTA Annual Congress
May 22, 2015 07:00 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., May 22, 2015 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces First Quarter 2015 Financial Results
May 13, 2015 17:00 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., May 13, 2015 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics to Present at Two International Vascular Access Conferences
April 13, 2015 08:00 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., April 13, 2015 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients with kidney...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces Positive Long-Term Results From Phase 2 Study of Investigational New Drug Vonapanitase in Chronic Kidney Disease Patients Undergoing Surgical Creation of an Arteriovenous Fistula for Hemodialysis
March 26, 2015 19:00 ET | Proteon Therapeutics, Inc.
DALLAS and WALTHAM, Mass., March 26, 2015 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics Announces Fourth Quarter and Full-Year 2014 Financial Results
March 20, 2015 07:00 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., March 20, 2015 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics to Present at the Cowen and Company 35th Annual Healthcare Conference on March 4th
February 26, 2015 08:00 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., Feb. 26, 2015 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...
New Proteon Logo - full color RGB.jpg
Proteon Therapeutics to Ring the Nasdaq Stock Market Opening Bell on February 9th
February 06, 2015 08:00 ET | Proteon Therapeutics, Inc.
WALTHAM, Mass., Feb. 6, 2015 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class pharmaceuticals to address the medical needs of patients with...